Abstract:Summary Background Extended-spectrum cephalosporins (ESCs) are third and fourth generation cephalosporin antimicrobials used in humans and animals to treat infections due to multidrug-resistant (MDR) bacteria. Resistance to ESCs (ESC-R) in Enterobacterales is predominantly due to the production of extended-spectrum β-lactamases (ESBLs) and plasmid-mediated AmpC β-lactamases (AmpCs). The dynamics of ESBLs and AmpCs are changing across countries and host species, the result of global transmission of ESC-R genes. Plasmids are known to play a key role in this dissemination, but the relative importance of different types of plasmids is not fully understood. Methods In this study, Escherichia coli with the major ESC-R genes bla CTX-M-1 , bla CTX-M-15 , bla CTX-M-14 (ESBLs) and bla CMY-2 (AmpC), were selected from diverse host species and other sources across Canada, France and Germany, collected between 2003 and 2017. To examine in detail the vehicles of transmission of the ESC-R genes, long- and short-read sequences were generated to obtain complete contiguous chromosome and plasmid sequences (n = 192 ESC-R E. coli ). The types, gene composition and genetic relatedness of these plasmids were investigated, along with association with isolate year, source and geographical origin, and put in context with publicly available plasmid sequences. Findings We identified five epidemic resistance plasmid subtypes with distinct genetic properties that are associated with the global dissemination of ESC-R genes across multiple E. coli lineages and host species. The IncI1 pST3 bla CTX-M-1 plasmid subtype was found in more diverse sources than the other main plasmid subtypes, whereas IncI1 pST12 bla CMY-2 was more frequent in Canadian and German human and chicken isolates. Clonal expansion also contributed to the dissemination of the IncI1 pST12 bla CMY-2 plasmid in ST131 and ST117 E. coli harbouring this plasmid. The IncI1 pST2 bla CMY-2 subtype was predominant in isolates from humans in France, while the IncF F31:A4:B1 bla CTX-M-15 and F2:A-:B- bla CTX-M-14 plasmid subtypes were frequent in human and cattle isolates across multiple countries. Beyond their epidemic nature with respect to ESC-R genes, in our collection almost all IncI1 pST3 bla CTX-M-1 and IncF F31:A4:B1 bla CTX-M-15 epidemic plasmids also carried multiple antimicrobial resistance (AMR) genes conferring resistance to other antimicrobial classes. Finally, we found genetic signatures in the regions surrounding specific ESC-R genes, identifying the predominant mechanisms of ESC-R gene movement, and using publicly available databases, we identified these epidemic plasmids from widespread bacterial species, host species, countries and continents. Interpretation We provide evidence that epidemic resistance plasmid subtypes contribute to the global dissemination of ESC-R genes, and in addition, some of these epidemic plasmids confer resistance to multiple other antimicrobial classes. The success of these plasmids suggests that they may have a fitness advantage over other plasmid types and subtypes. Identification and understanding of the vehicles of AMR transmission are crucial to develop and target strategies and interventions to reduce the spread of AMR. Funding This project was supported by the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), through the Medical Research Council (MRC, MR/R000948/1 ), the Canadian Institutes of Health Research ( CFC-150770 ), and the Genomics Research and Development Initiative ( Government of Canada ), the German Federal Ministry of Education and Research (BMBF) grant no. 01KI1709 , the French Agency for food environmental and occupational health & safety (Anses), and the French National Reference Center (CNR) for antimicrobial resistance. Support was also provided by the Biotechnology and Biological Sciences Research Council (BBSRC) through the BBSRC Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent project BBS/E/F/000PR103 -Abstract Truncated-

Antimicrobial resistance-associated mutations in chromosomal genes of ESKAPE pathogens

How can we escape the ESKAPEs: Antimicrobial resistance mechanisms and what lies ahead?

Antimicrobial Resistance Traits and Resistance Mechanisms in Bacterial Pathogens

The Resistance and Aminoglycoside-Modifying Enzyme Genotypes of High-Level Amino-Glycoside Resistant Enterococcus

Comparative genome analysis reveals putative and novel antimicrobial resistance genes common to the nosocomial infection pathogens

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics

An escape from ESKAPE pathogens: A comprehensive review on current and emerging therapeutics against antibiotic resistance

Antimicrobial Resistance Genes Analysis of Publicly Available Staphylococcus aureus Genomes

Antimicrobial Resistance Profile of Zoonotic Clinically Relevant WHO Priority Pathogens

The mobilome landscape of biocide-resistance in Brazilian ESKAPE isolates

Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases

Insights into Kinases of ESKAPE Pathogens for Therapeutic Interventions

Antimicrobial resistance in the wild: Insights from epigenetics

Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae

Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae Strain

Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance

Global transmission of extended-spectrum cephalosporin resistance in Escherichia coli driven by epidemic plasmids

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates

Genetic basis of antimicrobial resistance, virulence features and phylogenomics of carbapenem-resistant Acinetobacter baumannii clinical isolates

Characteristics and phylogenetic distribution of megaplasmids and prediction of a putative chromid in Pseudomonas aeruginosa